Results 181 to 188 of about 2,667 (188)
Some of the next articles are maybe not open access.
Ravulizumab significantly reduced relapses in AQP4+ NMOSD
Medicom Conference Report ECTRIMS 2022, 2022openaire +1 more source
Ravulizumab cost effective for paroxysmal nocturnal haemoglobinuria
PharmacoEconomics & Outcomes News, 2020openaire +1 more source
Keine Wirksamkeit von Ravulizumab bei ALS
DNP – Die Neurologie & PsychiatrieAlbert C. Ludolph +1 more
openaire +1 more source

